Clinical Medicine Insights: Oncology Emerging Trends in Hepatocellular Carcinoma: Focus on Diagnosis and Therapeutics

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study.

  2013cited by this paper
• Sorafenib or placebo in combination with transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEBDOX) for intermediate-stage hepatocellular carcinoma (HCC): Phase II, randomized, double-blind SPACE trial.

  2012cited by this paper
• Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns.

  2012cited by this paper
• Effectiveness of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis

  2012cited by this paper
• Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT

  2012cited by this paper
• Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria

  2012cited by this paper
• Activity of cabozantinib (XL184) in hepatocellular carcinoma patients (pts): Results from a phase II randomized discontinuation trial (RDT).

  2012cited by this paper
• Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version

  2011cited by this paper
• Management of hepatocellular carcinoma: An update

  2011cited by this paper
• Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma.

  2011cited by this paper
• Adjuvant Therapy after Curative Treatment for Hepatocellular Carcinoma

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Phase III trial of sunitinib (Su) versus sorafenib (So) in advanced hepatocellular carcinoma (HCC).

  2011cited by this paper
• Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.

  2011cited by this paper
• A phase II study of ramucirumab as first-line monotherapy in patients (pts) with advanced hepatocellular carcinoma (HCC).

  2010cited by this paper
• Design and rationale for the non-interventional Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) study

  2010cited by this paper
• Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.

  2010cited by this paper
• Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.

  2010cited by this paper
• Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.

  2010cited by this paper
• Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis.

  2010cited by this paper
• Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma

  2010cited by this paper
• Meta‐analysis: surveillance with ultrasound for early‐stage hepatocellular carcinoma in patients with cirrhosis

  2009cited by this paper
• Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.

  2009cited by this paper
• Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

  2009cited by this paper
• Epidemiology of hepatocellular carcinoma in Japan

  2009cited by this paper
• Pivotal role of mTOR signaling in hepatocellular carcinoma.

  2008cited by this paper
• Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

  2008cited by this paper
• Excellent outcome following down‐staging of hepatocellular carcinoma prior to liver transplantation: An intention‐to‐treat analysis

  2008cited by this paper
• Sorafenib in advanced hepatocellular carcinoma.

  2008cited by this paper
• Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

  2007cited by this paper
• Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.

  2007cited by this paper
• Clinical Utility of AFP-L3% Measurement in North American Patients with HCV-Related Cirrhosis

  2007cited by this paper
• Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma

  2007cited by this paper
• European Association for the Study of the Liver

  2006cited by this paper
• Liver Tumor Characterization: Comparison Between Liver-specific Gadoxetic Acid Disodium-enhanced MRI and Biphasic CT-A Multicenter Trial

  2006cited by this paper
• Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially‐enhancing liver mass

  2005cited by this paper
• Resection and Liver Transplantation for Hepatocellular Carcinoma

  2005cited by this paper
• Knockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivo

  2005cited by this paper
• A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

  2005cited by this paper
• Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

  2004cited by this paper
• Randomized controlled trial of screening for hepatocellular carcinoma

  2004cited by this paper
• Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

  2003cited by this paper
• In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.

  2003cited by this paper
• Predictors and patterns of recurrence after resection of hepatocellular carcinoma.

  2003cited by this paper
• Des‐gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

  2003cited by this paper
• Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description.

  2002cited by this paper
• Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

  2002cited by this paper
• Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation

  1999cited by this paper
• [A prospective study of early detection for primary liver cancer].

  1996cited by this paper
• Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

  1996cited by this paper
• Hepatocellular carcinoma.

  1986cited by this paper
• Basic issues in population screening for cancer.

  1980cited by this paper
• Clinical Medicine Insights: Oncology

  year unknowncited by this paper

• PTGES3 proteolysis using the liposomal peptide-PROTAC approach

  2024cites this paper
• Role of glypican-3 and heppar-1 in categorization of hepatic space occupying lesions in imaging guided fine needle aspiration cytology

  2024cites this paper
• The Cyclophilin Inhibitor Rencofilstat Decreases HCV-induced Hepatocellular Carcinoma Independently of Its Antiviral Activity

  2023cites this paper
• The Cyclophilin Inhibitor Rencofilstat Decreases HCV-Induced Hepatocellular Carcinoma Independently of Its Antiviral Activity

  2023cites this paper
• Radiolabeling of statistically optimized nanosized atorvastatin suspension for liver targeting and extensive imaging of hepatocellular carcinoma

  2023cites this paper
• A high-throughput test enables specific detection of hepatocellular carcinoma

  2023cites this paper
• Prevalence of HIV and Viral Hepatitis Markers among Healthcare Workers in the Republic of Guinea

  2023influential citation
• The ratio of serum des‐gamma‐carboxy prothrombin to tumor volume as a new biomarker for early recurrence of resected hepatocellular carcinoma

  2022cites this paper
• Cancer epigenetics in clinical practice

  2022cites this paper
• Demographic Profile and Etiology of Hepatocellular Carcinoma in Zaria, Northern Nigeria

  2022cites this paper
• Seroprevalence and Factors Associated with Risk of Hepatitis B Virus Infection among Antenatal Attendees in ABUTH Zaria, Northwestern Nigeria

  2022cites this paper
• Myostatin as a fibroblast‐activating factor impacts on postoperative outcome in patients with hepatocellular carcinoma

  2021cites this paper
• Serum Golgi protein 73 and glypican-3: early diagnostic biomarkers for hepatocellular carcinoma

  2021cites this paper
• Hepatitis B virus compartmentalization and single-cell differentiation in hepatocellular carcinoma

  2021cites this paper
• Anti fibrogenesis effect of green materials Moringa oleifera leaf powder (MOLP) on the progression of hepatocellular carcinoma

  2021cites this paper
• Значимость лабораторной диагностики парентеральных вирусных гепатитов в Гвинейской Республике

  2021cites this paper
• Plasma MicroRNAs as Biomarkers for HCV Related Hepatocellular ‎Carcinoma: Diagnostic Performance of a microRNA Panel in Egyptian ‎Patients‎ ‎

  2021cites this paper
• Rapid glycosylation analysis of mouse serum glycoproteins separated by supported molecular matrix electrophoresis.

  2021cites this paper
• Transcriptional regulation of alcohol induced liver fibrosis in a translational porcine hepatocellular carcinoma model.

  2021cites this paper
• Aglycemic growth enhances carbohydrate metabolism and induces sensitivity to menadione in cultured tumor-derived cells

  2021cites this paper
• epiLiver a novel tumor specific, high throughput and cost-effective blood test for specific detection of liver cancer (HCC)

  2021cites this paper
• The Effects of Dandelion Polysaccharides on Iron Metabolism by Regulating Hepcidin via JAK/STAT Signaling Pathway

  2021cites this paper
• PATZ1 (MAZR) Co-occupies Genomic Sites With p53 and Inhibits Liver Cancer Cell Proliferation via Regulating p27

  2021cites this paper
• epi Liver a novel tumor specific, high throughput and cost-effective blood test for specific detection of liver cancer (HCC)

  2021cites this paper
• Non-viral gene delivery of the oncotoxic protein NS1 for treatment of hepatocellular carcinoma.

  2021cites this paper
• Transcriptional Profiling of Porcine HCC Xenografts Provides Insights Into Tumor Cell Microenvironment Signaling

  2021cites this paper
• Characterizing human α-1,6-fucosyltransferase (FUT8) substrate specificity and structural similarities with related fucosyltransferases

  2020cites this paper
• The Relevance of MicroRNAs in the Pathogenesis and Prognosis of HCV-Disease: The Emergent Role of miR-17-92 in Cryoglobulinemic Vasculitis

  2020cites this paper
• Loss of core fucosylation in both ST6GAL1 and its substrate enhances glycoprotein sialylation in mice.

  2020cites this paper
• A genetic variant in the promoter of CD46 is associated with the risk and prognosis of hepatocellular carcinoma

  2020cites this paper
• Exosomal miRNAs in hepatitis B virus related liver disease: a new hope for biomarker

  2020cites this paper
• RETRACTED ARTICLE: MiR-616 plays oncogenic role in hepatocellular carcinoma progression through suppressing PTEN expression and activating PI3K/AKT pathway

  2020cites this paper
• Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3

  2020cites this paper
• Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease.

  2020cites this paper
• Evaluation of the diagnostic and therapeutic roles of non-coding RNA and cell proliferation related gene association in hepatocellular carcinoma.

  2019cites this paper
• Tubulin colchicine site binding agent LL01 displays potent antitumor efficiency both in vitro and in vivo with suitable drug-like properties

  2019cites this paper
• A Microfabricated Sandwiching Assay for Nanoliter and High-Throughput Biomarker Screening.

  2019cites this paper
• Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis

  2019cites this paper
• Traditional Chinese Medicine (TCM) Astragalus Membranaceus and Curcuma Wenyujin Promote Vascular Normalization in Tumor-derived Endothelial Cells of Human Hepatocellular Carcinoma

  2019cites this paper
• Effectiveness of Noninvasive Fibrosis Markers for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B and Chronic Hepatitis B+D Induced Cirrhosis.

  2019cites this paper
• Hepatocellular Carcinoma: Combined Transarterial Chemoembolization and Ablation

  2019cites this paper
• Hepatic copper and other trace mineral concentrations in dogs with hepatocellular carcinoma

  2019cites this paper
• Tuning T‐Cell Receptor Affinity to Optimize Clinical Risk‐Benefit When Targeting Alpha‐Fetoprotein–Positive Liver Cancer

  2019cites this paper
• Studying the Impact of Golgi Protein 73 Serving as a Candidate Biomarker in Early Diagnosis for Hepatocellular Carcinoma among Saudi Patients

  2019cites this paper
• Impact of vascular endothelial growth factor on prognosis of patients with hepatocellular carcinoma treated with angiotensin-converting-enzyme inhibitors

  2018cites this paper
• Detection of a lipid peroxidation-induced DNA adduct across liver disease stages.

  2018cites this paper
• MicroRNA‐125b expression and intrahepatic metastasis are predictors for early recurrence after hepatocellular carcinoma resection

  2018cites this paper
• MicroRNA‐27a‐3p inhibits cell viability and migration through down‐regulating DUSP16 in hepatocellular carcinoma

  2018cites this paper
• Fluorescence sensing platform based on ruthenium(II) complexes as high 3S (sensitivity, specificity, speed) and "on-off-on" sensors for the miR-185 detection.

  2018cites this paper
• Survivin-targeted drug screening platform identifies a matrine derivative WM-127 as a potential therapeutics against hepatocellular carcinoma.

  2018cites this paper
• Preventive Effects of Vitamin C on Diethylnitrosamine-induced Hepatotoxicity in Smp30 Knockout Mice.

  2018cites this paper
• The signature of liver cancer in immune cells DNA methylation

  2018cites this paper
• Association of serum microRNA-125 b and HBV-related hepatocellular carcinoma in Chinese Han patients

  2018cites this paper
• Characterization of an Inducible Alcoholic Liver Fibrosis Model for Hepatocellular Carcinoma Investigation in a Transgenic Porcine Tumorigenic Platform.

  2018cites this paper
• Comparison of gadoxetic acid disodium-enhanced MRI and biphasic spiral CT in detection of hepatocellular carcinoma in patients meeting the Milan criteria

  2018cites this paper
• Plasmin-Binding Tripeptide-Decorated Liposomes Loading Pyrazolo[3,4-d]pyrimidines for Targeting Hepatocellular Carcinoma.

  2018cites this paper
• Lower expression of tumor microRNA‐26a is associated with higher recurrence in patients with hepatocellular carcinoma undergoing surgical treatment

  2018influential citation
• Decorating protein nanospheres with lactoferrin enhances oral COX-2 inhibitor/herbal therapy of hepatocellular carcinoma.

  2018cites this paper
• Fast and facile analysis of glycosylation and phosphorylation of fibrinogen from human plasma—correlation with liver cancer and liver cirrhosis

  2018cites this paper
• N-Substituted Pyrido-1,4-Oxazin-3-Ones Induce Apoptosis of Hepatocellular Carcinoma Cells by Targeting NF-κB Signaling Pathway

  2018cites this paper
• Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.

  2018influential citation
• Role of Myeloperoxidase in hepatitis C virus related hepatocellular carcinoma

  2018cites this paper
• Clinical Manifestations of Liver Disease in Diabetes Mellitus

  2018cites this paper
• Novel role of apatinib as a multi-target RTK inhibitor in the direct suppression of hepatocellular carcinoma cells.

  2018cites this paper
• SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer

  2017cites this paper
• Identifying key regulating miRNAs in hepatocellular carcinomas by an omics’ method

  2017cites this paper
• 3′UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma

  2017cites this paper
• Regulation of SIRT1/AMPK axis is critically involved in gallotannin-induced senescence and impaired autophagy leading to cell death in hepatocellular carcinoma cells

  2017cites this paper
• NSCA-1-a novel N-substituted coumalamide derivative-increases Adriamycin sensitivity in HepG2/adriamycin cells through modulating Akt/GSK-3β signaling and p53-dependant apoptotic pathway.

  2017cites this paper
• CRISPR/Cas9-mediated genome engineering of CXCR4 decreases the malignancy of hepatocellular carcinoma cells in vitro and in vivo.

  2017cites this paper
• Biological functions of fucose in mammals.

  2017cites this paper
• An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma

  2017cites this paper
• Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study.

  2017cites this paper
• Hepatitis C virus infection causes apoptosis and pyroptosis in both infected and bystander cells

  2017influential citation
• Overexpression of cofactor of BRCA1 in HepG2 Cells: A step towards understanding the role of COBRA1 in hepatocellular carcinoma

  2017cites this paper
• Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case‐control study

  2017cites this paper
• Adoption of Sorafenib for the Treatment of Advanced-Stage Hepatocellular Carcinoma in Oncology Practices in the United States

  2017cites this paper
• Overexpression of interleukin-32α promotes invasion by modulating VEGF in hepatocellular carcinoma.

  2017cites this paper
• Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy.

  2017cites this paper
• Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients

  2017cites this paper
• High-Performance Poly(lactic-co-glycolic acid)-Magnetic Microspheres Prepared by Rotating Membrane Emulsification for Transcatheter Arterial Embolization and Magnetic Ablation in VX2 Liver Tumors.

  2017cites this paper
• Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.

  2016cites this paper
• Guttiferone K suppresses cell motility and metastasis of hepatocellular carcinoma by restoring aberrantly reduced profilin 1

  2016cites this paper
• Down-regulation of β-arrestin2 promotes tumour invasion and indicates poor prognosis of hepatocellular carcinoma

  2016cites this paper
• Serum microRNA profiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma

  2016cites this paper
• Chest wall hernia induced by high intensity focused ultrasound treatment of unresectable massive hepatocellular carcinoma: A case report.

  2016cites this paper
• Protective effects of Celastrol on diethylnitrosamine-induced hepatocellular carcinoma in rats and its mechanisms.

  2016cites this paper
• Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey

  2016cites this paper
• Introduction Sorafenib as an adjuvant therapy for resectable hepatocellular carcinoma : A single center experience

  2016cites this paper
• Haemochromatosis and gastrointestinal cancer

  2016cites this paper
• Antiangiogenic and antihepatocellular carcinoma activities of the Juniperus chinensis extract

  2016influential citation
• CTNNA3 is a tumor suppressor in hepatocellular carcinomas and is inhibited by miR-425

  2016cites this paper
• Hepatitis C virus: A time for decisions. Who should be treated and when?

  2016cites this paper
• NRAGE promotes the malignant phenotype of hepatocellular carcinoma.

  2016influential citation
• VEGF Polymorphisms Related to Higher Serum Levels of Protein Identify Patients with Hepatocellular Carcinoma

  2016cites this paper
• Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma: Brazilian Survey

  2016cites this paper
• Distinguishing Cancerous Liver Cells Using Surface-Enhanced Raman Spectroscopy

  2016cites this paper
• Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study.

  2016cites this paper
• Regional differences in sorafenib‐treated patients with hepatocellular carcinoma: GIDEON observational study

  2016cites this paper
• Splenectomy suppresses growth and metastasis of hepatocellular carcinoma through decreasing myeloid-derived suppressor cells in vivo

  2016cites this paper